Primary Nonadherence, Associated Clinical Outcomes, and Health Care Resource Use Among Patients with Rheumatoid Arthritis Prescribed Treatment with Injectable Biologic Disease-Modifying Antirheumatic Drugs

BACKGROUND: Adherence to biologic disease-modifying antirheumatic drugs (bDMARDs) among patients with rheumatoid arthritis (RA) is often suboptimal in routine clinical practice. Low or nonadherence can reduce the effectiveness of bDMARD therapies. OBJECTIVE: To evaluate filling of newly prescribed i...

Descripción completa

Detalles Bibliográficos
Autores principales: Harnett, James, Wiederkehr, Daniel, Gerber, Robert, Gruben, David, Bourret, Jeffrey, Koenig, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403817/
https://www.ncbi.nlm.nih.gov/pubmed/27003550
http://dx.doi.org/10.18553/jmcp.2016.22.3.209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403817/
https://www.ncbi.nlm.nih.gov/pubmed/27003550
http://dx.doi.org/10.18553/jmcp.2016.22.3.209

Ejemplares similares